Staar Surgical CO Schedule 13G passive stakes

Several Madison Avenue-affiliated entities and Eli Samaha have reported a combined beneficial ownership of 8.4% of STAAR SURGICAL CO's common stock as of June 30, 2026.

Point72 Asset Management, L.P., along with affiliated entities and Steven A. Cohen, has reported beneficial ownership of 5.2% of STAAR Surgical Company's common stock as of May 11, 2026.

Madison Avenue Partners and affiliated entities have reported a 5.8% beneficial ownership stake in STAAR Surgical Co.

The Vanguard Group filed an Amendment No. 8 to Schedule 13G for STAAR Surgical Co, reporting 0% beneficial ownership following an internal realignment.

Armistice Capital, LLC and Steven Boyd have reported a complete divestment of their beneficial ownership in STAAR Surgical Co., now holding 0.00% of common stock.

Soleus Capital Master Fund and related entities have reported a 1.0% beneficial ownership stake in STAAR Surgical Company, totaling 500,000 shares.

Armistice Capital, LLC and Steven Boyd have disclosed a 5.67% beneficial ownership stake in STAAR Surgical Co., holding 2,812,000 common shares.

The Vanguard Group has updated its beneficial ownership in STAAR Surgical Co, reporting an 8.86% stake as of June 30, 2025.

Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a passive beneficial ownership of 6.08% in STAAR Surgical Co., totaling 3,000,000 common shares.

BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, disclosing a continued beneficial ownership of 15.0% in STAAR Surgical Co. as of March 31, 2025.

Soleus Capital Master Fund, L.P. and its affiliated entities have reported a passive beneficial ownership of 5.2% in STAAR Surgical Company, totaling 2,562,893 shares.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 16.7% of STAAR Surgical Co.'s common stock as of December 31, 2024.